{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T11:06:56Z","timestamp":1777028816179,"version":"3.51.4"},"reference-count":32,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.ejphar.2012.09.030","type":"journal-article","created":{"date-parts":[[2012,10,3]],"date-time":"2012-10-03T18:45:14Z","timestamp":1349289914000},"page":"96-100","source":"Crossref","is-referenced-by-count":15,"title":["Involvement of the sigma1 receptor in the antidepressant-like effects of fluvoxamine in the forced swimming test in comparison with the effects elicited by paroxetine"],"prefix":"10.1016","volume":"696","author":[{"given":"Yumi","family":"Sugimoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Tagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiharu","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kumiko","family":"Mitsui-Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Hotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2012.09.030_bib1","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00213-011-2293-5","article-title":"Fluvoxamine enhances prefrontal dopaminergic neurotransmission in adrenalectomized\/castrated mice via both 5-HT reuptake inhibition and sigma(1) receptor activation","volume":"217","author":"Ago","year":"2011","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2012.09.030_bib2","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1254\/jphs.CRJ04005X","article-title":"The role of sigma receptors in depression","volume":"97","author":"Bermack","year":"2005","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2012.09.030_bib3","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1124\/jpet.104.066472","article-title":"Effects of the potential antidepressant OPC-14523 [1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2-quinolino ne monomethanesulfonate] a combined sigma and 5-HT1A ligand: modulation of neuronal activity in the dorsal raphe nucleus","volume":"310","author":"Bermack","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2012.09.030_bib4","doi-asserted-by":"crossref","first-page":"8165","DOI":"10.1523\/JNEUROSCI.1816-05.2005","article-title":"Genotype-dependent activity of tryptophan hydroxylase-2 determines the response to citalopram in a mouse model of depression","volume":"25","author":"Cervo","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2012.09.030_bib5","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00213-002-1335-4","article-title":"Antidepressant-like effects in various mice strains in the forced swimming test","volume":"66","author":"David","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2012.09.030_bib6","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ejphar.2007.02.019","article-title":"Involvement of the sigma1 receptor in inhibiting activity of fluvoxamine on marble-burying behavior: comparison with paroxetine","volume":"563","author":"Egashira","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2012.09.030_bib7","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2165\/00003495-200060040-00006","article-title":"Fluvoxamine. An updated review of its use in the management of adults with anxiety disorders","volume":"60","author":"Figgitt","year":"2000","journal-title":"Drugs"},{"key":"10.1016\/j.ejphar.2012.09.030_bib8","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/01.fbp.0000236266.34182.1c","article-title":"Role of serotonin type 1A receptors in fluvoxamine-induced inhibition of marble-burying behavior in mice","volume":"17","author":"Harasawa","year":"2006","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.ejphar.2012.09.030_bib9","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/sj.npp.1301047","article-title":"Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of fluvoxamine: role of sigma-1 receptors","volume":"32","author":"Hashimoto","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2012.09.030_bib10","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S0022-3565(24)39299-7","article-title":"Ca(2+) signaling via sigma(1)-receptors: novel regulatory mechanism affecting intracellular Ca(2+) concentration","volume":"293","author":"Hayashi","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2012.09.030_bib11","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1254\/jjp.68.65","article-title":"5-HT1A-receptor subtype mediates the effect of fluvoxamine, a selective serotonin reuptake inhibitor, on marble-burying behavior in mice","volume":"68","author":"Ichimaru","year":"1995","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2012.09.030_bib12","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s10519-006-9106-3","article-title":"Feeling strained? Influence of genetic background on depression-related behavior in mice: a review","volume":"37","author":"Jacobson","year":"2007","journal-title":"Behav. Genet."},{"key":"10.1016\/j.ejphar.2012.09.030_bib13","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1017\/S1461145708008547","article-title":"Further evidence for an antidepressant potential of the selective sigma1 agonist SA 4503: electrophysiological, morphological and behavioural studies","volume":"11","author":"Lucas","year":"2008","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.ejphar.2012.09.030_bib14","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1017\/S1461145708008547","article-title":"Further evidence for an antidepressant potential of the selective sigma1 agonist SA 4503: electrophysiological, morphological and behavioural studies","volume":"11","author":"Lucas","year":"2008","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.ejphar.2012.09.030_bib15","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s002130100694","article-title":"Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice","volume":"155","author":"Lucki","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2012.09.030_bib16","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0165-0173(01)00112-6","article-title":"The interaction between neuroactive steroids and the sigma1 receptor function: behavioral consequences and therapeutic opportunities","volume":"37","author":"Maurice","year":"2001","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.ejphar.2012.09.030_bib17","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0014-2999(96)00254-3","article-title":"Interactions of selective serotonin reuptake inhibitors with subtypes of sigma receptors in rat brain","volume":"307","author":"Narita","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2012.09.030_bib18","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/00004714-200102000-00008","article-title":"Augmentation of fluoxetine's antidepressant action by pindolol: analysis of clinical, pharmacokinetic, and methodologic factors","volume":"21","author":"Perez","year":"2001","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2012.09.030_bib19","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00213-004-2048-7","article-title":"Forced swimming test in mice: a review of antidepressant activity","volume":"177","author":"Petit-Demouliere","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2012.09.030_bib20","first-page":"327","article-title":"Behavioural despair in mice: a primary screening test for antidepressants","volume":"229","author":"Porsolt","year":"1977","journal-title":"Arch. Int. Pharmacodyn."},{"key":"10.1016\/j.ejphar.2012.09.030_bib21","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1097\/00001756-199809140-00028","article-title":"Sigma (sigma1) receptor mediated antidepressant-like effects of neurosteroids in the Porsolt forced swim test","volume":"9","author":"Reddy","year":"1998","journal-title":"Neuroreport"},{"key":"10.1016\/j.ejphar.2012.09.030_bib22","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.bbr.2008.11.036","article-title":"Sigma-1 receptor knockout mice display a depressive-like phenotype","volume":"198","author":"Sabino","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2012.09.030_bib23","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1023\/A:1006986824213","article-title":"Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding","volume":"19","author":"Sanchez","year":"1999","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.ejphar.2012.09.030_bib24","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1248\/bpb.25.1479","article-title":"The 5-HT2 receptor antagonist reduces immobility of mice treated with the atypical antidepressant mianserin in the forced swimming test","volume":"25","author":"Sugimoto","year":"2002","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejphar.2012.09.030_bib25","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ejphar.2008.07.005","article-title":"Mouse strain differences in immobility and sensitivity to fluvoxamine and desipramine in the forced swimming test: analysis of serotonin and noradrenaline transporter binding","volume":"592","author":"Sugimoto","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2012.09.030_bib26","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ejphar.2009.11.057","article-title":"Involvement of the 5-HT1A receptor in the anti-immobility effects of fluvoxamine in the forced swimming test and mouse strain differences in 5-HT1A receptor binding","volume":"629","author":"Sugimoto","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2012.09.030_bib27","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ejphar.2011.10.002","article-title":"Differences between mice strains in response to paroxetine in the forced swimming test: involvement of serotonergic or noradrenergic systems","volume":"672","author":"Sugimoto","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2012.09.030_bib28","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S0022-3565(24)29502-1","article-title":"The antidepressant-like effect induced by sigma(1)-receptor agonists and neuroactive steroids in mice submitted to the forced swimming test","volume":"298","author":"Urani","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2012.09.030_bib29","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1254\/jphs.10191FP","article-title":"Pharmacological interaction with the sigma1 (sigma1)-receptor in the acute behavioral effects of antidepressants","volume":"115","author":"Villard","year":"2011","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2012.09.030_bib30","doi-asserted-by":"crossref","first-page":"655","DOI":"10.2165\/00003495-200262040-00010","article-title":"Paroxetine: an update of its use in psychiatric disorders in adults","volume":"62","author":"Wagstaff","year":"2002","journal-title":"Drugs"},{"key":"10.1016\/j.ejphar.2012.09.030_bib31","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0006-3223(96)00043-1","article-title":"Dehydroepiandrosterone (DHEA) treatment of depression","volume":"41","author":"Wolkowitz","year":"1997","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2012.09.030_bib32","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0006-8993(02)03684-3","article-title":"Differential effects of the 5-HT2 receptor antagonist on the anti-immobility effects of noradrenaline and serotonin reuptake inhibitors in the forced swimming test","volume":"958","author":"Yamada","year":"2002","journal-title":"Brain Res."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299912008047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299912008047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T22:42:51Z","timestamp":1744238571000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299912008047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":32,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0014299912008047"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2012.09.030","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}